TachoSil is a Topical Patch in the Human Prescription Drug category. It is labeled and distributed by Baxalta Us Inc.. The primary component is Human Thrombin; Fibrinogen Human.
Product ID | 0944-8701_e7ac607f-3b8c-4e7f-aaec-e9421b020e62 |
NDC | 0944-8701 |
Product Type | Human Prescription Drug |
Proprietary Name | TachoSil |
Generic Name | Thrombin Human And Fibrinogen |
Dosage Form | Patch |
Route of Administration | TOPICAL |
Marketing Start Date | 2010-04-05 |
Marketing End Date | 2020-05-31 |
Marketing Category | BLA / BLA |
Application Number | BLA125351 |
Labeler Name | Baxalta US Inc. |
Substance Name | HUMAN THROMBIN; FIBRINOGEN HUMAN |
Active Ingredient Strength | 2 [USP'U]/1; mg/1 |
Pharm Classes | Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [CS],Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [CS] |
NDC Exclude Flag | N |
Marketing Start Date | 2010-04-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125351 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-04-05 |
Marketing End Date | 2020-05-31 |
Ingredient | Strength |
---|---|
HUMAN THROMBIN | 2 [USP'U]/1 |
SPL SET ID: | 5918e503-b457-48ab-b68b-243e29651d06 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0338-8701 | TachoSil | THROMBIN HUMAN and FIBRINOGEN |
0338-8702 | TachoSil | THROMBIN HUMAN and FIBRINOGEN |
0338-8703 | TachoSil | THROMBIN HUMAN and FIBRINOGEN |
0944-8701 | TachoSil | THROMBIN HUMAN and FIBRINOGEN |
0944-8702 | TachoSil | THROMBIN HUMAN and FIBRINOGEN |
0944-8703 | TachoSil | THROMBIN HUMAN and FIBRINOGEN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TACHOSIL 78284603 2951400 Live/Registered |
TAKEDA AS 2003-08-07 |
TACHOSIL 77870559 3878803 Live/Registered |
TAKEDA AS 2009-11-11 |